Modulation of the KEAP1–NRF2 Pathway for the Treatment of Neurodegenerative Diseases: Rationale, Assay Methodologies, and Reference Compounds
Crossref DOI link: https://doi.org/10.1007/978-1-0716-4232-0_5
Published Online: 2024-12-27
Published Print: 2025
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Clerigué, José
Pascual, Jorge
León, Rafael
Menéndez, J. Carlos
Text and Data Mining valid from 2024-12-27
Version of Record valid from 2024-12-27
Chapter History
First Online: 27 December 2024